News
Brief news reports on Tuberculosis
By
Delthia Ricks
Published: July 23, 2020, 5:15 p.m.·
Tags:
Scientific research
Inadequate development of new antibiotics and rising rates of resistance by bacteria to existing antimicrobials are dual forces pushing the world ever closer to a post-antibiotic era.
Read More →
By
Kamal Kant Kohli
Published: July 23, 2020, 5 p.m.·
Tags:
Latent TB,
Prevention
Researchers have found in a new study that vitamin D supplementation did not result in a lower risk of TB infection or TB disease. The study has been published in the New England Journal of Medicine.
Read More →
By
Tufts University
Published: July 23, 2020, 2:33 p.m.·
Tags:
Scientific research
Technology combines rapid imaging and machine learning to uncover patterns in how antibacterials kill; can be applied to many pathogens
Read More →
By
Global TB Caucus
Published: July 22, 2020, 7:55 p.m.·
Tags:
Global TB response,
Advocacy
The Global TB Caucus released a newsletter listing the key activities and outcomes of the Caucus for the first half of 2020.
Read More →
By
Jeongmin Kim
Published: July 22, 2020, 5:23 p.m.·
Tags:
Global TB response
The Indian government sent $1 million worth of anti-tuberculosis medicine to North Korea per a request from the World Health Organization (WHO), according to a press release issued by the Indian embassy in Pyongyang on Wednesday (July 22).
Read More →
By
Mylan,
TB Alliance
Published: July 22, 2020, 3:11 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access
Pretomanid is only the third new anti-tuberculosis (TB) drug developed specifically for drug-resistant forms of the disease to be approved in more than 40 years
Approval comes as a result of Mylan’s global collaboration with non-profit drug development partner TB Alliance
Read More →
By
World Health Organization
Published: July 22, 2020, 2:14 p.m.·
Tags:
Treatment
22 July 2020, Geneva | The World Health Organization (WHO) Global Tuberculosis Programme has initiated a process for the collection and assessment of evidence on whether the dosing of rifampicin, isoniazid, ethambutol and pyrazinamide requires further optimization to safely improve treatment success and reduce unfavourable treatment outcomes in TB patients on first-line treatment regimens.
Read More →
By
Global Coalition of TB Activists,
Stop TB Partnership,
Northwestern Pritzker School of Law
Published: July 21, 2020, 11:15 p.m.·
Tags:
Global TB response,
Advocacy
A technical brief for policymakers and program implementers - a joint effort of the Global Coalition of TB Activists, the Stop TB Partnership and the Northwestern Pritzker School of Law.
Read More →
By
Xinhua
Published: July 21, 2020, 5:29 p.m.·
Tags:
TB programs
JAKARTA, July 21 -- Indonesian President Joko Widodo on Tuesday ordered authorities to aggressively trace those infected by mycobacterium tuberculosis and the COVID-19 virus at the same time in a bid to bring down the number of cases.
Read More →
By
Stop TB Partnership
Published: July 20, 2020, 1:32 p.m.·
Tags:
Diagnostics
20 July 2020, Geneva, Switzerland- The Stop TB Partnership and the Foundation for Innovative New Diagnostics (FIND) today launched an online resource center of computer-aided detection (CAD) products for the diagnosis of tuberculosis (TB): www.ai4hlth.org.
Read More →
Page 180 of 895 · Total posts: 10
←First
179
180
181
Last→